Deise Catamo Vaz/LinkedIn
Apr 2, 2026, 14:18
Deise Catamo Vaz: Closing A Large Information Gap in PSCI Through WSO Future Stroke Leaders Project
Deise Catamo Vaz, Neurologist at UEM Cardiology Research Center, shared on LinkedIn:
”The Post-stroke cognitive impairment (PSCI) is a significant, yet often overlooked, cause of persistent disability, affecting over one-third of stroke survivors.
However, we have limited knowledge about global practices and barriers in screening for cognitive impairment among stroke survivors.
We present our global project, divided into two phases:
- Survey and systematic review, led by members of the World Stroke Organization (WSO) Future Stroke Leaders Programme (FSLP), seeks to address this gap.
- Our main objective with this project is to understand the current situation and knowledge of healthcare professionals who care for patients after stroke globaly, with a strong emphasis in LMICs.
At the end of this project, we will have more information to improve the diagnosis of PSCI and vascular dementia, especially in LMICs, closing a large information gap in these area.
World Stroke Organization Future Stroke Leaders Cohort-3.”

Stay updated with Hemostasis Today.
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy